MYERS SCOTT DUNSETH received a stock award from ZENTALIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/18/2025ACC: 0001725160-25-000129
Director
Since Nov 2024
+57.60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
57.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+57.60K
Price / share
—
Trade value
—
% of position
20.5%
6/17/2025
281.19K→338.80K
Total
Net shares
+57.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/17/2025 | A · Award | +57.60K | — | — | 20.5% | 281.19K | 338.80K |
| Total | +57.60K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported